Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Jul 2026
News, features, and commentary about cancer-related issues
Read Full News1.
Cancer After Weight Loss; How Older Adults Use the Healthcare System.
2.
Mortality up for children with leukemia from lowest SES neighborhoods
3.
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer
4.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
5.
Trial Supports Ivonescimab and Chemo for NSCLC Survival
1.
Emerging Therapies Through Personalized Tumor Ecosystem Remodeling
2.
Clinical Guidelines for Neutropenic Complication Monitoring
3.
Novel Antibody Conjugates in Cancer: Mechanisms, Clinical Evidence, and Therapeutic Implications
4.
Platelet Dysfunction During Severe Systemic Inflammation: Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches
5.
What is Mullerian and How Does it Affect Your Health
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
2.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
4.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
5.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge